PillEmpagliflozin
Brands: Jardiance · Empagliflozin
4 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | unknown | 8 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | unknown | 8 | SUPPLYING |
| A-S Medication Solutions | unknown | 6 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 9, 2023RECALLRecall (Class II): JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90) …
Labeling: Label Mix-up — Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc. — Product was distributed nationwide within the United States and PR
- Jan 26, 2022RECALLRecall (Class II): Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: B…
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — Recalling firm: CARDINAL HEALTHCARE — Nationwide USA